LAURUSLABS1,942.50

Laurus Labs Ltd.

· Pharma & Health
AnnualQuarterly₹ CrorePeersDIVISLABGLANDMANKINDBIOCONALKEMLUPINFORTISGLENMARKMcap ₹1.05L Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Revenue from Operations5,040.85,554.06,812.98,839.2
Other Income26.375.155.064.1
Total Income5,067.25,629.16,867.98,903.3
Expenses
+ Cost of Materials Consumed2,422.42,428.62,794.33,580.1
+ Purchases of Stock-in-Trade110.9105.4172.6207.7
+ Changes in Inventories-100.9-55.9-271.4-336.3
+ Employee Benefit Expense639.9719.5895.51,154.2
+ Finance Costs182.9216.0170.7213.0
+ Depreciation & Amortisation384.6430.1480.1603.9
+ Other Expenses1,191.01,301.21,444.31,817.6
Total Expenses4,830.85,144.85,686.07,240.1
EBITDA777.51,055.31,777.72,416.0
EBIT392.9625.21,297.71,812.1
Profit
PBT before Exceptional Items236.4484.31,181.91,663.2
Pretax Income236.4484.31,181.91,663.2
+ Current Tax93.1156.9297.5432.4
+ Deferred Tax-25.0-27.0-5.5-21.0
Tax Expense68.2129.9292.0411.4
+ Share of Associates & JVs-5.93.90.30.4
Net Income162.3358.3890.11,252.2
+ Net Income — Continuing Ops168.2354.4889.91,251.8
+ Other Comprehensive Income-2.9-3.7-5.9-8.1
Total Comprehensive Income159.4354.7884.21,244.1
Net Income to Common160.6358.3888.81,256.4
Minority Interest1.70.01.4-4.2
Per Share
Basic EPS2.986.6516.4723.28
Diluted EPS2.976.6416.4523.25
Other Comprehensive Income — detail
+ Other Comprehensive Income-3.7-5.9-8.1
+ Items NOT to be Reclassified to P&L-1.2-1.42.80.4
+ Tax on Items NOT to be Reclassified0.00.0-0.6
+ Tax on Items NOT to be Reclassified — alt tag-0.3
+ Items to be Reclassified to P&L-2.0-2.3-8.7-9.1
Comprehensive Income — Owners of Parent157.7354.7882.91,248.3
Comprehensive Income — Non-controlling Interests1.70.01.3-4.2
Per Share — as-filed variants
Basic EPS — Continuing Operations2.986.6516.4723.28
Diluted EPS — Continuing Operations2.976.6416.4523.25
Derived — Gross Profit (Revenue − Materials − Purchases − Δ Inventories)
Gross Profit2,608.43,076.04,117.45,387.7
Gross Margin %51.7555.3860.4460.95
Adjusted (ex-Exceptional Items) — derived
Pretax Income (Adjusted, as filed)236.4484.31,181.91,663.2
Net Income Adj (tax-effected)162.3358.3890.11,252.2
EPS Adj2.986.6516.4723.28
Other Filed Concepts — mapped but not yet placed in the schedule
Face Value2.002.002.002.00
Paid Up Equity Capital107.8107.9108.0108.1
As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.